期刊文献+

受体相互作用蛋白1RIP1在食管鳞癌的表达及意义 被引量:2

Expression and significance of receptor interacting protein 1 in esophageal squamous cell cancer
下载PDF
导出
摘要 目的明确受体相互作用蛋白1 RIP1在人食管鳞癌组织中的表达及与临床病理因素、病人预后的关系。方法使用免疫组化SP法检测76例人食管鳞癌组织和相对应的癌旁正常食管黏膜中RIP1的表达状况,并分析与临床病理因素如病人的性别、年龄、肿瘤大小、浸润深度、临床分期、分级、有无淋巴结转移的关系,并进行了随访。结果76例食管鳞癌中RIP1阳性的病例有53例,占69.7%,癌旁组织RIP1阳性的只有19例,占25%,差异有统计学意义,RIP1的阳性表达与病人的性别、年龄、肿瘤大小无关,与浸润深度、临床分期、分级、有无淋巴结转移成正相关,随访结果表明:食管鳞癌中RIP1阳性率越高,病人生存期越短,预后越差,RIP1蛋白的表达是个预后不良的独立因素。结论 RIP1在食管鳞癌中表达增高,可能参与食管鳞癌的发生。 Objective To investigate the expression of receptor interacting protein 1(RIP1) in esophageal squamous cell cancer(ESCC) and its link with clinical pathologic data and prognosis.Methods Imunohistochemistry was applied to analysize the expression status of RIP1 in seventy-six esophageal squamous cell cancer tissues and corresponding adjacent paracancerous normal tissues.Then Kaplan-Meier survival analysis and Cox proportional hazard regression model was used to test the association between expression status of RIP1 and clinical pathologic data,total survival rate induced from follow-up.Results Among 76 cases,positive expression of RIP1 in ESCC tissues was found in 53 cases and it accounts for 69.7%.Positive rate in corresponding adjacent normal tissues was 25%.The difference was significant.Moreover,positive rate of RIP1 in cancerous tissues was positive related to invasion depth,clinical stage,pathologic grade,lymph node metastasis,but it was not associated with patient’s sex,age,tumor mass.Follow-up suggested positive rate was more higher,patient’survival time was more shorter,prognosis was more worse.Expression of RIP1 was an independent bad prognosis predictor.Conclusions Expression of RIP1 in ESCC is high and maybe it participates in the pathogenesis of ESCC.
出处 《解剖学研究》 CAS 2013年第3期182-185,共4页 Anatomy Research
基金 湖北省教育厅重点项目(D20122802) 湖北科技学院重大项目培育课题(PY1104) 湖北科技学院博士启动基金(BK0908) 2011年湖北科技学院大学生科研创新课题(12010501008)
关键词 食管鳞癌 受体相互作用蛋白1 免疫组化SP法 Esophageal squamous cell cancer Receptor interacting protein 1 Imunohistochemistry
  • 相关文献

参考文献10

  • 1Stanger BZ, Leder P, Lee TH, et al. RIP: a novel pro- tein containing a death domain that interacts with Fas/ APO-1 (CD95) in yeast and causes cell death. Cell, 1995 , 81 : 513-523.
  • 2Grimm S, Stanger BZ, Leder P. RIP and FADD: two "death domain"-eontaining proteins can induce apoptosis by convergent, but dissoeiable, pathways. Proc Natl Acad Sci U S A, 1996;93: 10923-10927.
  • 3Park S, Ramnarain DB, Hatanpaa K J, et al. The death domain-ontaining kinase RIP1 regulates p27 (Kipl) levels through the PI3K-Akt-forkhead pathway. EMBO Rep, 2008 ; 9 : 766-773.
  • 4Vivarelli MS, McDonald D, Miller M, et al. RIP links TLR4 to Akt and is essential for cell survival in response to ~ stimulation. J Exp Med, 2004;200:399-404.
  • 5Meylan E, Tschopp J. The RIP kinases: crucial integra- tors of cellular stress. Trends Biochem Sci, 2005;30:151- 159.
  • 6Festjens N, Vanden Berghe T, Cornelis S, et al. RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ, 2007 ; 14 : 400-410.
  • 7Park S, Hatanpaa K J, Xie Y, et al. The receptor inter- acting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma. Cancer Res, 2009, 69(7) :2809-2816.
  • 8Bellail AC, Olson JJ, Yang X, et al. A20 ubiquitin lig- ase-mediated polyubiquitination of RIP1 inhibits caspase- 8 cleavage and TRAIL-induced apoptosis in glioblastoma. Cancer Discov, 2012, 2(2) : 140-155.
  • 9Xu G, Tan X, Wang H, et al. Ubiquitin-specific pepti- dase 21 inhibits tumor necrosis factor alpha-induced nu- clear factor kappaB activation via binding to and deubiqui- tinating receptor-interacting protein 1. J Biol Chem, 2010,285 (2) : 969-978.
  • 10Ye YC, Wang HJ, Yu L, et al. RIPl-mediated mito- chondrial dysfunction and ROS production contributed to tumor necrosis factor alpha-induced L929 cell necroptosis and autophagy. Int Immunopharmacol, 2012, 14 (4) : 674-682.

同被引文献18

  • 1Jemal A, Siegel R, Xu J,et al. Cancer statistics,2010 [J]. CA Cancer J Clin ,2010,60 ( 5 ) :277 - 300.
  • 2Christofferson D E, Li Y, Yuan J. Control of life-or-death deci~ sions by RIP1 kinase [ J ]. Annu Rev Physiol, 2014,76 : 129 - 50.
  • 3Ofengeim D, Yuan J. Regulation of RIP1 kinase signalling at the crossroadsof inflammation and cell death [ J ]. Nat Rev Mol CellBiol,2013,14( 11 ) :727 -36.
  • 4Jain M V, Paczulla A M, Klonisch T,et al. Interconneetions be- tween apoptotie, autophagic and necrotic pathways: implieations for eaneer therapy development[J].J Cell Mol Med,2013,17 (1) :12 -29.
  • 5Kovalenko A, Chahle-Bessia C, Cantarella G,et al. The tumour suppressor CYLD negatively regulates NF-KB signalling by deubiq- uitination [J].Nature ,2003,424(6950) :801 - 5.
  • 6Declereq W, Vanden Berghe T, Vandenabeele P. RIP kinases at the crossroads of cell death and survival[J]. Cell,2009,138 (2) : 229 - 32.
  • 7Li J, MeQuade T, Siemer A B,et al. The RIPI/RIP3 neerosome forms a functional amyloid signaling eomplex required for pro- grammed necrosis[J]. Cell, 2012, 150(2) : 339 -50.
  • 8Liu X Y, Lai F, Yan X G, et al. RIP1 kinase is an oncogenic driver in melanoma[J]. Cancer Res,2015,75 ( 8 ) : 1736 - 48.
  • 9Habib A A, Chatteljee S, Park S K, et al. The epidermal growth factor receptor engages receptor interacting protein and nuclear fac- tor-kappa B (NF-kappaB)-inducing kinase to activate NF-kappa B. Identification of a novel receptor-tyrosine kinase signalosome [ J]. J Biol Chem, 2001,276(12) :8865 - 74.
  • 10Wertz I E, OPtourke K M, Zhou H, et al. De-ubiquitination and ubiquitinligase domains of A20 downregulate NF-KB signalling [ J ]. Nature, 2004,430 ( 7000 ) : 694 - 9.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部